~~<i id='FF5B821862'><strike id='FF5B821862'><tt id='FF5B821862'><pre id='FF5B821862'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

Wikipedia

knowledge

author：leisure time 2025-09-27 09:58:07 - browse：5

Editor’s note: A recording of the event is embedded below.

After a few go-go years, the early-stage biotech market has cooled considerably. Two VCs will weigh in on what distinguishes great science from bad investments.

Featured Speakers

Irena Melnikova, Ph.D., partner, Pfizer Ventures
Rakhshita Dhar, senior director, venture investments, Leaps by Bayer
Frank S. David, M.D., Ph.D., managing director, Pharmagellan (moderator)

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： At least 13 dead in Texas as scorching temps continue
Next article： STAT readers on older presidents, polypills, Medicare, and more

knowledge

hotspot

leisure time

focus

hotspot

AlisonSbranaattheNIHClinicalCenterinBethesda,Md.,participatesinastudyonmyalgicencephalomyelitis/chro

WSS

Neurocrine Biosciences, biotech based in San Diego, joins PhRMA

Antivenom research: Lessons from HIV applied in search for universal antidote

4 killed, 7 hurt in mass shooting at July 4 block party in Louisiana; no arrests made

New case study details death in closely watched Alzhiemer's trial

Antivenom research: Lessons from HIV applied in search for universal antidote

Pfizer's Covid pill remains 89% effective in final analysis, company says

Wikipedia

knowledge

Featured Speakers

knowledge

Activists slam private health insurers over coverage restrictions

New case study details death in closely watched Alzhiemer's trial

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

Pfizer's Covid pill remains 89% effective in final analysis, company says

Walensky prepares to leave CDC — and Congress — behind

STAT readers on older presidents, polypills, Medicare, and more

Medicare details structure of new drug price negotiation program

He's a Nobel laureate. Critics say he was misleading on Covid

Jerome Adams on the need for new antivirals for Covid

NIH study of ME/CFS points to clear biological hallmarks

hotspot

Listen: Biogen's messy board & Laronde's data problem

Option Care buys Amedisys in $3.6 billion home care deal

Grail is spending more than ever lobbying Congress

New documents shed light on MD Anderson Cancer Institute feud

When is a doctor not a doctor? Try when patients address women doctors

Ukraine, Russia accuse each other of planning to attack Europe's biggest nuclear plant

leisure time

focus

hotspot

hotspot